arginine has been researched along with bibp 3226 in 237 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 82 (34.60) | 18.2507 |
| 2000's | 96 (40.51) | 29.6817 |
| 2010's | 57 (24.05) | 24.3611 |
| 2020's | 2 (0.84) | 2.80 |
| Authors | Studies |
|---|---|
| Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W | 1 |
| Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 2 |
| Braunger, H; Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 1 |
| Cadieux, A; Dumont, Y; Jacques, D; Quirion, R | 1 |
| Beck-Sickinger, AG; Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 1 |
| Abounader, R; Hamel, E; Villemure, JG | 1 |
| Lundberg, JM; Modin, A | 1 |
| Beck-Sickinger, AG; Eberlein, W; Engel, W; Herzog, H; Martinez, R; Munoz, M; Rudolf, K; Sautel, M; Walker, P; Wittneben, H | 1 |
| Dumont, Y; Quirion, R; St-Pierre, JA | 1 |
| Lundberg, JM; Malmstrom, RE | 2 |
| Dayao, EK; Doods, HN; Hauser, GJ; Karwatowska-Prokopczuk, E; Zukowska-Grojec, Z | 1 |
| Cox, HM; Tough, IR | 1 |
| Cox, HM; Holliday, ND | 1 |
| Ekelund, M; Grundemar, L | 1 |
| Cantera, L; Edvinsson, L; Nilsson, T | 1 |
| Cantera, L; Edvinsson, L; Erlinge, D; Nilsson, T | 1 |
| Bucher, B; Doods, HN; Gicquiaux, H; Tschöpl, M | 1 |
| Finnman, UB; Fuxe, K; Yang, SN | 1 |
| Bergdahl, A; Cantera, L; Edvinsson, L; Erlinge, D; Hedner, T; Nilsson, L; Nilsson, T; Sun, XY; Valdemarson, S | 1 |
| Harro, J; Kask, A; Rägo, L | 5 |
| Ekelund, U; Erlinge, D | 1 |
| Edvinsson, L; Hedner, T; Sun, XY; Zhao, XH | 1 |
| Adham, N; Boyle, N; Branchek, TA; Cui, W; Dhanoa, DS; Dowling, B; Du, P; Gluchowski, C; Hou, C; Islam, I; Rueger, H; Salon, JA; Schmidlin, T; Shifman, Y; Tamm, JA; Vaysse, PJ; Walker, MW; Weinshank, RL; Yamaguchi, Y | 1 |
| Kennedy, B; Shen, GH; Ziegler, MG | 1 |
| Avramidis, P; Bischoff, A; Erdbrügger, W; Michel, MC; Münter, K | 1 |
| Grundemar, L; Ny, L | 1 |
| Chujo, M; Ito, K; Mohammed, MU; Mori, H; Nakazawa, H; Sekka, T; Shinozaki, Y; Tanaka, E; Tobita, K; Yamakawa, A | 1 |
| Balmér, KC; Lundberg, JM; Malmström, RE | 1 |
| Dumont, Y; Fournier, A; Pheng, LH; Quirion, R; Regoli, D | 1 |
| Besecke, LM; Leupen, SM; Levine, JE | 1 |
| Donoso, MV; Guzmán, S; Huidobro-Toro, JP; Racchi, H; Rahmer, A; Rudolf, K; Schliem, AJ; Zúñiga, A | 1 |
| Donoso, MV; Huidobro-Toro, JP; Steiner, M | 1 |
| De Backer, JP; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Brown, N; Carrasco, C; Cortes, V; Donoso, MV; Fournier, A; Huidobro-Toro, JP | 1 |
| Fournier, A; Iyengar, S; Pheng, LH; Quirion, R; Regoli, D | 1 |
| Bischoff, A; Freund, A; Michel, MC | 1 |
| Grundemar, L | 2 |
| Buckingham, R; Henderson, L; Upton, R; Widdowson, PS; Williams, G; Wilson, S | 1 |
| Chen, X; Cox, BF; Han, S; Naes, L; Westfall, T; Yang, CL | 1 |
| Buckingham, R; Widdowson, PS; Williams, G | 1 |
| Barrios, VE; Nelson, AG; Toombs, CF | 1 |
| Lundberg, JM; Thorén, P; Zhang, W | 2 |
| Gribkoff, VK; Pieschl, RL; van den Pol, AN; Wisialowski, TA; Yocca, FD | 1 |
| Adner, M; Duckles, SP; Edvinsson, L; Krause, DN | 1 |
| Ech-Chadli, H; Lafond, J; Robidoux, J; Simoneau, L; St-Pierre, S | 1 |
| Bruns, RF; Gehlert, DR; Schober, DA; Smiley, DL; Van Abbema, AM | 1 |
| Bischoff, A; Michel, MC | 1 |
| De Backer, JP; Fraeyman, N; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Cavaleri, D; Conti, M; Gariboldi, M; Samanin, R; Vezzani, A | 1 |
| Andersson, A; Carlsson, PO; Jansson, L | 1 |
| Capurro, D; Donoso, V; Huidobro-Toro, JP; Mezzano, V | 1 |
| Burhop, KE; Drapeau, G; Moisan, S; Rioux, F | 1 |
| Aiglstorfer, I; Bernhardt, G; Buschauer, A; Dove, S; Gessele, K; Malawska, B; Merz, S; Moser, C; Schuster, A; Uffrecht, A | 1 |
| Beck-Sickinger, AG; Eriksson, H; Grundemar, L; Holmberg, SK; Larhammar, D; Sharma, P | 1 |
| Björkman, JA; Byström, M; Ekstrand, AJ; Hökfelt, T; Lundberg, JM; Malmström, RE; Nihlén, C | 1 |
| García-Sacristán, A; Prieto, D; Simonsen, U | 1 |
| DeBacker, JP; Ebinger, G; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Dayao, EK; Hauser, GJ; Qureshi, NU; Shirali, S; Zukowska-Grojec, Z | 1 |
| Beauverger, P; Bourrienne, A; Boutin, JA; Canet, E; Dromaint, S; Duhault, J; Fauchère, JL; Félétou, M; Galizzi, JP; Germain, M; Henlin, JM; Imbert, J; Macia, C; Nicolas, JP; Rodriguez, M | 1 |
| Arch, JR; Buckingham, RE; Haynes, AC; McClue, S; Wilson, S | 1 |
| Abusnana, S; Bloom, S; Ghatei, M; Goldstone, AP; Gunn, I; Heath, M; Meeran, K; Morgan, DG; O'Shea, D; Rossi, M; Small, CJ; Smith, DM; Turton, M | 1 |
| Hexum, TD; Zhang, P; Zheng, J | 1 |
| Howard, M; Huidobro-Toro, JP; Irarrázabal, MJ; Morán, S; Racchi, H; Zalaquett, R | 1 |
| Iyengar, S; Li, DL; Simmons, RM | 1 |
| Brown, N; Cortés, V; Donoso, MV; Fanjul, R; Fournier, A; Huidobro-Toro, JP; López, C | 1 |
| Oberhauser, V; Rump, LC; Vonend, O | 2 |
| Harro, J; Kask, A; Kivastik, T; Rägo, L | 1 |
| Bijak, M | 1 |
| Costa, A; Forsling, ML; Grossman, AB; Korbonits, M; Little, JA; Navarra, P; Trainer, PJ; Tringali, G | 1 |
| Capurro, D; Huidobro-Toro, JP | 1 |
| Koyama, T; Nakagawa, S; Nishi, N; Odagaki, Y | 1 |
| Carroll, M; Hinson, JP; Kapas, S; Renshaw, D; Thomson, LM | 1 |
| Bergdahl, A; Edvinsson, L; Hedner, T; Sun, XY; Zhao, XH | 1 |
| Andrianjara, CR; Calvet, A; Dahl, SG; Pascal, Y; Sylte, I | 1 |
| Beck-Sickinger, AG; Colmers, WF; Ho, MW | 1 |
| Hexum, TD; Vorce, RL; Zhang, P; Zheng, J | 1 |
| Brunkvall, J; Edvinsson, L; Lind, H; Nilsson, T | 1 |
| Conti, M; Rizzi, M; Samanin, R; Vezzani, A | 1 |
| Harro, J; Kask, A; Rägo, L; Schiöth, HB; Wikberg, JE | 1 |
| Chouffani, S; El-Bizri, N; Hassan, G; Jacques, D; Sader, S; Shbaklo, H | 1 |
| Harro, J; Kask, A | 1 |
| Casellas, P; Lafontan, M; Le Fur, G; Maffrand, JP; Marchand, J; Pascal, M; Pouzet, B; Raufaste, D; Serradeil-Le Gal, C | 1 |
| Bolwig, TG; Greisen, MH; Madsen, TM; Mikkelsen, JD; Nielsen, SM | 1 |
| Hoyo, Y; McGrath, JC; Vila, E | 1 |
| Aiglstorfer, I; Bernhardt, G; Buschauer, A; Dove, S; Hendrich, I; Moser, C | 1 |
| Lafond, J; Masse, A; Robidoux, J; Simoneau, L; St-Pierre, S | 1 |
| Chiba, S; Yang, XP | 3 |
| Lin, X; Narnaware, YK; Peter, RE; Peyon, PP | 1 |
| Diéguez, G; Fernández, N; García-Villalón, AL; Gómez, B; Martínez, MA; Monge, L; Padilla, J | 1 |
| Bobalova, J; Mutafova-Yambolieva, VN; Smyth, L; Ward, SM | 1 |
| Adham, N; Artymyshyn, R; Bonini, JA; Borowsky, B; Boteju, LW; Boyle, N; Branchek, TA; Durkin, MM; Forray, C; Gerald, C; Jones, KA; Kouranova, EV; Lakhlani, PP; Ogozalek, KL; Quan, Y; Raddatz, R; Smith, KE; Tamm, JA; Vaysse, PJ; Wetzel, JM; Yao, WJ | 1 |
| Gaillard, RC; Giacomini, M; Grouzmann, E; Pralong, FP; Voirol, M | 1 |
| Bryan, RM; Edvinsson, L; You, J | 1 |
| Cox, HM; Holliday, ND; Tough, IR; Zandvliet, DW | 1 |
| Akk, G; Huguenard, JR; Prince, DA; Sun, QQ | 1 |
| Cox, HM; Herzog, H; Pollock, EL; Tough, IR | 1 |
| Bratt, AM; Hodge, CW; Kelley, SP; Nannini, MA | 1 |
| Eipper, BA; Hansel, DE; Ronnett, GV | 1 |
| Detheux, M; Doods, H; Dumont, Y; Gouardères, C; Kotani, M; Mollereau, C; Parmentier, M; Quirion, R; Zajac, JM | 1 |
| Ishiguchi, T; Kumagai, AK; Nakajima, M; Sone, H; Tada, H; Takahashi, T | 1 |
| Abbott, CR; Bloom, SR; Dakin, CL; Ghatei, MA; Morgan, DG; Russell, SH; Small, CJ | 1 |
| Peter, RE; Volkoff, H | 1 |
| De Backer, JP; Ebinger, G; Vanderheyden, PM; Vauquelin, G | 1 |
| Beauvillain, JC; Chuoï, MM; Croix, D; Jirou-Najou, JL; Knauf, C; Mortreux, G | 1 |
| Bucher, B; Dieterlen, A; Gaire, M; Galzi, JL; Gicquiaux, H; Lecat, S; Mély, Y; Takeda, K | 1 |
| Chen, SH; Cheung, RT; Fung, PC | 1 |
| Parker, E; Stamford, A; Van Heek, M | 1 |
| Bell, D; McDermott, BJ; Nicholl, SM; Spiers, Jp | 1 |
| Banchelli, G; Matucci, R; Pirisino, R; Raimondi, L; Stillitano, F | 1 |
| Detheux, M; Dumont, Y; Kotani, M; Lannoy, V; Marcus, D; Mazarguil, H; Mollereau, C; Parmentier, M; Quelven, I; Quirion, R; Zajac, JM | 1 |
| Audinot, V; Beauverger, P; Boutin, JA; Dromaint, S; Galizzi, JP; Imbert, J; Lamamy, V; Macia, C; Nicolas, JP; Rique, H; Rodriguez, M | 1 |
| Bolwig, TG; Gruber, SH; Husum, H; Mathé, AA | 1 |
| Herzog, H; Potter, EK; Smith-White, MA | 1 |
| Chen, SH; Cheung, RT | 2 |
| Carvalho, AP; Carvalho, CM; Malva, JO; Silva, AP | 1 |
| Hexum, TD; Zheng, J; Zhou, G | 1 |
| Browning, KN; Travagli, RA | 1 |
| Bell, D; Bradley, E; Johnson, CD; Law, A | 1 |
| Cox, HM; Herzog, H; Hyland, NP; Sjöberg, F; Tough, IR | 1 |
| Kobelt, P; Mönnikes, H; Mronga, S; Rüter, J; Schäfer, MK; Tebbe, JJ | 1 |
| Beck-Sickinger, A; Dumont, Y; Fournier, A; Quirion, R; Thakur, M | 1 |
| Feng, GG; Hotta, Y; Ishikawa, A; Ishikawa, N; Kurimoto, N; Nan, YS; Nishiwaki, K; Shigei, T; Shimada, Y | 1 |
| Hodge, CW; Koenig, H; Olive, F; Schroeder, JP | 1 |
| Fang, L; Lin, Q; Ren, Y; Wang, J; Willis, WD; Zou, X | 1 |
| Cho, YR; Kim, CW | 1 |
| Higuchi, H; Honglan, P; Tsurumaki, T | 1 |
| Jackson, DN; Noble, EG; Shoemaker, JK | 1 |
| Flores, CM; Gibbs, J; Hargreaves, KM | 1 |
| Engström, M; Panula, P; Savola, JM; Wurster, S | 1 |
| Bennett, LA; Johnson, JM; Kosiba, WA; Saad, AR; Stephens, DP | 1 |
| Jackson, DN; Milne, KJ; Noble, EG; Shoemaker, JK | 1 |
| Beck, B; Stricker-Krongrad, A | 1 |
| Mronga, S; Ritter, M; Schäfer, MK; Tebbe, CG; Tebbe, JJ | 1 |
| Cusick, MC; Primeaux, SD; Wilson, MA; Wilson, SP; York, DA | 1 |
| Chang, M; Chen, LX; Chen, Q; Fang, Q; Guo, J; Wang, R | 1 |
| Habbel, S; Okonek, A; Quack, I; Rump, LC; Stegbauer, J; Vonend, O | 1 |
| Akerberg, H; Berglund, MM; Holmberg, SK; Larhammar, D; Mohell, N; Sjödin, P | 1 |
| Buckwalter, JB; Clifford, PS; Hamann, JJ | 1 |
| Arnold, R; Mronga, S; Ortmann, E; Schäfer, MK; Tebbe, CG; Tebbe, JJ | 1 |
| Ehlers, CL; Slawecki, CJ; Thorsell, A | 1 |
| Acuna-Goycolea, C; van den Pol, AN | 1 |
| Chevé, G; McCurdy, CR; Mollereau, C; Vyas, N | 1 |
| Chang, M; Fang, Q; Guo, J; He, F; Peng, YL; Wang, R | 1 |
| Ijames, SG; Lysle, DT; Saurer, TB | 1 |
| Brill, J; Fernald, RD; Huguenard, JR; Lee, M; Zhao, S | 1 |
| Deshmukh, M; Lal, B; Mazumdar, M; Sakharkar, AJ; Singru, PS; Subhedar, N | 1 |
| Allen, AR; Bell, D; Dickson, P; Kelso, EJ; McDermott, BJ; Zhao, Y | 1 |
| Kaiya, H; Kangawa, K; Maruyama, K; Matsuda, K; Miura, T; Shimakura, S; Shioda, S; Uchiyama, M | 1 |
| Brownfield, MS; DeJoseph, MR; Dimitrov, EL; Urban, JH | 1 |
| Carrigan, KA; Ijames, SG; Lysle, DT; Saurer, TB | 1 |
| Bernhardt, G; Brennauer, A; Buschauer, A; Gross, D; Hoefelschweiger, BK; Keller, M; Schneider, E; Wolfbeis, OS | 1 |
| Berglund, MM; Gehlert, DR; Morin, M; Schober, DA | 1 |
| Das, P; Dong, W; Ji, Y; Miksa, M; Ravikumar, TS; Wang, P; Wu, R; Yang, D; Zhang, F; Zhou, M | 1 |
| Dubinion, JH; Jackson, EK; Mi, Z | 1 |
| Boissoneault, J; Bruijnzeel, AW; Isaac, S; Prado, M; Rylkova, D; Shah, HP | 1 |
| Hodges, GJ; Johnson, JM; Kosiba, WA; Zhao, K | 1 |
| Harte, AL; Kos, K; Kumar, S; McTernan, PG; O'Hare, PJ | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; König, B; Weiss, S | 2 |
| Laughlin, MH; Taylor, JC; Terjung, RL; Yang, HT | 1 |
| Connelly, JJ; Crosslin, DR; Crossman, DC; Freedman, NJ; Ginsburg, GS; Goldschmidt-Clermont, PJ; Granger, CB; Gregory, SG; Hauser, ER; Haynes, C; Johnson, J; Jones, CJ; Kraus, WE; Muehlbauer, M; Nelson, S; Newgard, CB; Shah, SH; Sketch, MH; Stone, DH; Vance, J; Wang, L; Zhang, L | 1 |
| Adame, A; Crews, L; Gage, FH; Hersh, LB; Mante, M; Marr, RA; Masliah, E; Potkar, R; Rockenstein, E; Rose, JB; Spencer, B | 1 |
| Bhisikar, SM; Goyal, SN; Kokare, DM; Subhedar, NK; Upadhya, MA | 1 |
| Dandekar, MP; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Belsham, DD; Dhillon, SS; Gingerich, S | 1 |
| Miyazaki, R; Yamada, T; Yamamoto, T | 1 |
| Dandekar, MP; Kokare, DM; Singru, PS; Subhedar, NK; Upadhya, MA | 1 |
| Kakinuma, N; Kawate, T; Narita, K; Takeda, S | 1 |
| Dandekar, MP; Deo, GS; Kokare, DM; Subhedar, NK; Upadhya, MA | 1 |
| Hegg, CC; Jia, C | 1 |
| Ellis, CG; Jackson, DN; Shoemaker, JK | 1 |
| Constantin, S; Klenke, U; Wray, S | 1 |
| Alsina-Fernandez, J; Coskun, T; Craft, L; Goebel, M; Rivier, J; Stengel, A; Taché, Y; Wang, L | 1 |
| Agasse, F; Cadet, JL; Coronas, V; Guégan, C; Jaber, M; Malva, JO; Nicoleau, C; Thiriet, N; Vallette, F | 1 |
| Körner, M; Reubii, JC; Thalmann, GN; Waser, B | 1 |
| Chopde, CT; Hirani, K; Kokare, DM; Kotagale, NR; Mali, PD; Nakhate, KT; Subhedar, NK; Taksande, BG; Ugale, RR | 1 |
| Chikahisa, S; Kitaoka, K; Nishino, S; Séi, H; Shimizu, N | 1 |
| Crespi, F | 1 |
| Gericke, MT; Klöting, N; Kosacka, J; Nowicki, M; Schröder, T; Spanel-Borowski, K | 1 |
| Chabeauti, PY; Chalon, S; Decressac, M; Frangeul, L; Gaillard, A; Herzog, H; Jaber, M; Pain, S; Thiriet, N; Vergote, J | 1 |
| Molina-Hernández, M; Téllez-Alcántara, NP | 1 |
| Cox, BR; Jijon, AM; Kash, TL; Li, C; Lowery-Gionta, EG; Navarro, M; Peňa, J; Pleil, KE; Rinker, JA; Sparrow, AM; Sprow, GM; Thiele, TE | 1 |
| Azuma, M; Kamijo, M; Kang, KS; Matsuda, K; Nishiguchi, R; Uchiyama, M; Yokobori, E | 1 |
| Kokare, DM; Nakhate, KT; Rangani, RJ; Subhedar, NK; Upadhya, MA | 1 |
| Beck-Sickinger, AG; Findeisen, M; Meier, R; Meiler, J; Olsson, R; Rathmann, D; Würker, C | 1 |
| Jackson, DN; Lacefield, JC; Medeiros, PJ; Shoemaker, JK; Twynstra, J | 1 |
| Gillespie, DG; Jackson, EK; Kochanek, SJ | 1 |
| Dong, S; Li, M; Ma, G; Zhou, L | 1 |
| Angulo, JA; Yarosh, HL | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Kuo, MH | 1 |
| Al-Khazraji, BK; Goldman, D; Jackson, DN; Medeiros, PJ; Novielli, NM | 1 |
| Jaakkola, U; Jääskeläinen, AE; Kakko, T; Kallio, J; Seppälä, S | 1 |
| Ai, J; Cai, BZ; Chen, QX; Liu, J; Sun, LH; Wang, N; Xie, F; Yang, BF; Ye, JH | 1 |
| Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M | 1 |
| Jiang, CL; Ni, HL; Wang, X; Wei, HF; Yang, F; Zhang, LD; Zhang, T; Zhou, JR | 1 |
| Azuma, M; Kikuyama, S; Matsuda, K; Morimoto, N; Shimizu, S | 1 |
| Fisher, SA; Mauban, JR; Raina, H; Wier, WG; Zacharia, J | 1 |
| Aglawe, MM; Kotagale, NR; Paliwal, NP; Taksande, BG; Umekar, MJ | 1 |
| Ai, J; Niu, HF; Xie, F; Xu, L; Yan, Y; Yang, BF | 1 |
| Bernhardt, G; Buschauer, A; Holzammer, T; Kaske, M; Keller, M | 1 |
| Hodges, GJ; Sparks, PA | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
| Bilbao, MG; Di Yorio, MP; Faletti, AG | 1 |
| Goebel-Stengel, M; Stengel, A; Taché, Y; Wang, L | 1 |
| Bharne, AP; Chopde, CT; Gawande, DY; Kokare, DM; Kotagale, NR; Taksande, BG | 1 |
| Cho, IJ; Kim, SC; Lee, BH; Wu, Y; Xu, Y; Yang, CH; Zhang, J; Zhao, R; Zhao, Z | 1 |
| Borkar, CD; Desai, SJ; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Ishii, T; Muroi, Y | 1 |
| Herbison, A; Liu, X | 1 |
| Balasubramaniam, A; Bertin, I; Bihel, F; Boon, P; Bourguignon, JJ; Buffel, I; Coppens, J; De Kock, J; De Prins, A; Hammoud, H; Humbert, JP; Maes, V; Massie, A; Meurs, A; Portelli, J; Schmitt, M; Simonin, F; Smolders, I; Tourwe, D; Utard, V; Vanhaecke, T | 1 |
| Kovács, A; László, K; Lénárd, L; Ollmann, T; Péczely, L; Zagorácz, O | 1 |
| Bharne, AP; Kokare, DM; Nakhate, KT; Subhedar, NK; Yedke, SU | 1 |
| Jiang, L; Jiang, S; Xu, W; Yu, W; Zhu, C | 1 |
| Anikina, TA; Krylova, AV; Masliuko, PM; Moiseev, KY; Zefirov, TL; Zverev, AA | 1 |
| Brothers, RM; Christmas, KM; Diller, KR; Khoshnevis, S; Patik, JC | 1 |
| Alencastre, IS; Barreiros, L; Barros, C; Domingues, MRM; Domingues, P; Lamghari, M; Melo, T; Segundo, MA; Silva, EMP; Varandas, PAMM | 1 |
| Babygirija, R; Cao, Y; Shi, B; Sun, W; Yang, Y; Zhang, F; Zheng, J; Zheng, X | 1 |
| Dong, P; Gu, X; Li, M; Ma, B; Zhu, G; Zi, Y | 1 |
| Kingston, R; Lacey, T; Markham, CM; Smith, M; Sweeting, J | 1 |
| Dai, W; Liu, Y; Lv, X; Sun, C; Sun, Y; Zhang, Y | 1 |
| Bai, Y; Becker, S; Cortes-Burgos, LA; Croll, SD; Eckersdorff, MM; Macdonald, LE; Ruiz, HH | 1 |
| Andberg, TAH; Åqvist, J; Brandsdal, BO; Gutiérrez-de-Terán, H; Isaksen, GV; Jespers, W; van Veen, A; Vasile, S | 1 |
| Chen, DY; Huang, TW; Li, ST; Young, TH | 1 |
| Alencastre, IS; Barreiros, L; Lamghari, M; Segundo, MA; Silva, EMP | 1 |
| Campos-Rodríguez, C; Chávez-Reyes, J; Marichal-Cancino, BA; Miranda-Páez, A; Ramírez-San Juan, E; Vázquez-León, P | 1 |
4 review(s) available for arginine and bibp 3226
| Article | Year |
|---|---|
Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.
Topics: Animals; Arginine; Binding, Competitive; Brain; Colon; Dose-Response Relationship, Drug; Gastrointestinal Hormones; Humans; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Peptide YY; Peptides; Rabbits; Radioligand Assay; Rats; Receptors, Neuropeptide Y; Saphenous Vein; Vas Deferens | 1995 |
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties.
Topics: Animals; Arginine; Calcium; Cyclic AMP; Eating; Heart; Humans; Presynaptic Terminals; Rabbits; Rats; Receptors, Neuropeptide Y | 1996 |
Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
Topics: Animals; Anti-Obesity Agents; Arginine; Body Weight; Energy Metabolism; Humans; Neuropeptide Y; Obesity; Pharmaceutical Preparations; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2002 |
Structure-activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives.
Topics: Amino Acid Sequence; Animals; Arginine; CHO Cells; Cricetinae; Cricetulus; Humans; Oligopeptides; Peptide Fragments; Receptors, Neuropeptide; Structure-Activity Relationship | 2006 |
233 other study(ies) available for arginine and bibp 3226
| Article | Year |
|---|---|
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Topics: Amino Acid Sequence; Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Perfusion; Rabbits; Rats; Rats, Inbred SHR; Receptors, Neuropeptide Y; Vas Deferens | 1995 |
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Topics: Adipocytes; Amino Acid Sequence; Animals; Arginine; Brain; Calcium; CHO Cells; Cricetinae; Dogs; Humans; Kidney; Male; Molecular Sequence Data; Neuroblastoma; Neuropeptide Y; Peptide Fragments; Rabbits; Rats; Receptors, Neuropeptide Y; Stereoisomerism; Substrate Specificity; Tumor Cells, Cultured | 1995 |
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226.
Topics: Arginine; Binding, Competitive; Cell Count; Humans; Kinetics; Neuroblastoma; Radioligand Assay; Receptors, Neuropeptide Y; Tritium; Tumor Cells, Cultured | 1995 |
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.
Topics: Animals; Arginine; Blood Pressure; Calcium; Perfusion; Rats; Receptors, Neuropeptide Y | 1994 |
Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
Topics: Adult; Amino Acid Sequence; Arginine; Cerebral Arteries; Female; Gastrointestinal Hormones; Humans; In Vitro Techniques; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Peptide YY; Peptides; Receptors, Neuropeptide Y; Vasoconstriction | 1995 |
Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Topics: Animals; Arginine; Cattle; Dogs; Drug Evaluation, Preclinical; Electric Stimulation; Female; Male; Neuropeptide Y; Radioligand Assay; Rats; Receptors, Neuropeptide Y; Reserpine; Stereoisomerism; Swine; Sympathetic Nervous System; Vasoconstriction | 1995 |
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Topics: Amino Acid Sequence; Arginine; Binding Sites; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1996 |
Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226.
Topics: Animals; Arginine; Autoradiography; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tritium | 1996 |
Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Sympathetic Nervous System; Vasoconstriction; Venae Cavae | 1995 |
Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors.
Topics: Animals; Arginine; Blood Pressure; Cold Temperature; Hemodynamics; Male; Mesenteric Arteries; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Regional Blood Flow; Stress, Mechanical; Vascular Resistance; Vasoconstriction | 1996 |
Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.
Topics: Animals; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Electric Stimulation; Electrodes; Gastrointestinal Hormones; Humans; Intestinal Mucosa; Jejunum; Male; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin | 1996 |
The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; HT29 Cells; Humans; Iodine Radioisotopes; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Peptides; Receptors, Neuropeptide Y; Somatostatin; Stimulation, Chemical; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1996 |
Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
Topics: Abdominal Muscles; Animals; Arginine; Blood Vessels; Guinea Pigs; Humans; In Vitro Techniques; Ligands; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Receptors, Neuropeptide Y; Vena Cava, Inferior | 1996 |
Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries.
Topics: Arginine; Base Sequence; Cerebral Arteries; DNA Primers; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Humans; Molecular Sequence Data; Neuropeptide Y; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Vasoconstriction | 1996 |
Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
Topics: Arginine; Arteries; Dose-Response Relationship, Drug; Humans; Neuropeptide Y; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Vasoconstriction | 1996 |
Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Topics: Animals; Arginine; Arteries; Blood Pressure; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide YY; Peptides; Phenylephrine; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide Y; Vasoconstrictor Agents | 1996 |
The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Solitary Nucleus | 1996 |
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
Topics: Adrenergic alpha-Agonists; Arginine; Drug Synergism; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Oligonucleotides, Antisense; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Transcription, Genetic | 1996 |
Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.
Topics: Animals; Anxiety; Arginine; Diazepam; Exploratory Behavior; GABA Modulators; Injections, Intraventricular; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone | 1996 |
In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
Topics: Animals; Arginine; Arteries; Blood Vessels; Cats; Dose-Response Relationship, Drug; Hindlimb; Male; Microcirculation; Muscle, Skeletal; Neuropeptide Y; Receptors, Neuropeptide Y; Regional Blood Flow; Sympathectomy; Vascular Resistance; Vasoconstrictor Agents; Veins | 1997 |
Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
Topics: Animals; Arginine; Blood Pressure; Electric Stimulation; Heart Rate; Hypertension; Male; Neuropeptide Y; Peripheral Nerves; Phenylephrine; Prazosin; Rats; Rats, Inbred SHR; Receptors, Neuropeptide Y; Stress, Physiological; Tyramine | 1997 |
Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites.
Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Cattle; Computer Simulation; GTP-Binding Proteins; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Neuropeptide Y; Protein Conformation; Protein Engineering; Receptors, Neuropeptide Y | 1997 |
Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system.
Topics: Amino Acid Sequence; Animals; Arginine; Blood Pressure; Electric Stimulation; Male; Molecular Sequence Data; Neuropeptide Y; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1997 |
Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Topics: Animals; Arginine; Kidney; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Regional Blood Flow | 1997 |
Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem.
Topics: Animals; Arginine; Colforsin; Cyclic AMP; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Solitary Nucleus | 1997 |
Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine; Coronary Vessels; Dogs; Female; Male; Neuropeptide Y; Norepinephrine; Potassium Channels; Receptors, Neuropeptide Y; Vascular Resistance; Vasoconstriction | 1997 |
The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Topics: Animals; Arginine; Blood Vessels; Electric Stimulation; Female; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Swine; Sympathetic Nervous System | 1997 |
The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.
Topics: Animals; Arginine; Biological Assay; Dogs; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Receptors, Neuropeptide Y; Saphenous Vein; Species Specificity; Swine; Vasoconstriction | 1997 |
Neuropeptide Y Y1-receptor stimulation is required for physiological amplification of preovulatory luteinizing hormone surges.
Topics: Animals; Arginine; Female; GABA Modulators; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Pentobarbital; Pulsatile Flow; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 1997 |
Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
Topics: Animals; Arginine; Electric Stimulation; Humans; In Vitro Techniques; Mesenteric Arteries; Mesenteric Veins; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sympathetic Nervous System; Vasoconstriction | 1997 |
BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Arginine; Electric Stimulation; Mesenteric Arteries; Neuropeptide Y; Norepinephrine; Prazosin; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Suramin; Sympathetic Nervous System | 1997 |
Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.
Topics: Animals; Arginine; Binding, Competitive; Guanylyl Imidodiphosphate; Half-Life; In Vitro Techniques; Membranes; Nerve Tissue Proteins; Neuropeptide Y; Prosencephalon; Proteins; Radioligand Assay; Rats; Receptors, Neuropeptide Y | 1997 |
Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
Topics: Animals; Arginine; Electric Stimulation; Guanethidine; Mesenteric Arteries; Nerve Endings; Neuropeptide Y; Norepinephrine; Oxidopamine; Perfusion; Rats; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System | 1997 |
The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
Topics: Animals; Appetite Stimulants; Arginine; Binding, Competitive; Diamines; Humans; Ileum; Naphthalenes; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Rabbits; Rats; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1997 |
Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Electric Stimulation; Female; Ischemia; Male; Neuropeptide Y; Norepinephrine; Peptide YY; Phenylephrine; Receptors, Neuropeptide Y; Renal Circulation; Reperfusion Injury; Swine; Sympathetic Nervous System; Time Factors; Vasoconstriction | 1997 |
The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.
Topics: Animals; Arginine; Drug Synergism; Hemodynamics; Male; Methoxamine; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Topics: Animals; Arginine; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Trachea | 1997 |
Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arginine; Cerebral Ventricles; Corticotropin-Releasing Hormone; Exploratory Behavior; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1997 |
Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat.
Topics: Amygdala; Animals; Arginine; Autoradiography; Binding Sites; Diet; Hypothalamus; Male; Obesity; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thalamic Nuclei; Tissue Distribution | 1997 |
Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Topics: Animals; Arginine; Electric Stimulation; Intestines; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System; Vasoconstriction | 1998 |
Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Topics: Animals; Arginine; Binding Sites; Binding, Competitive; Brain; Iodine Radioisotopes; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1997 |
BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
Topics: Animals; Arginine; In Vitro Techniques; Male; Neuropeptide Y; Pancreatic Polypeptide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sympathetic Nervous System; Vasoconstriction | 1998 |
Neuropeptide Y Y1 receptor antagonist (BIBP 3226) attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Blood Pressure; Epinephrine; Heart Rate; Hypertension; Norepinephrine; Rats; Rats, Inbred SHR; Receptors, Neuropeptide Y; Stress, Psychological | 1997 |
Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Arginine; Bicuculline; Circadian Rhythm; Electrophysiology; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Neural Inhibition; Neuropeptide Y; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus | 1998 |
Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
Topics: Animals; Arginine; Arteries; Electric Stimulation; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Transmission; Tail; Vasoconstriction | 1997 |
Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.
Topics: Adenylyl Cyclases; Arginine; Cell Membrane; Chromones; Enzyme Inhibitors; Estrenes; Female; Humans; Inositol 1,4,5-Trisphosphate; Microvilli; Morpholines; Neuropeptide Y; Peptide YY; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Pregnancy; Protein Kinase C; Pyrrolidinones; Receptors, Neuropeptide Y; Trophoblasts; Type C Phospholipases | 1998 |
The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
Topics: Animals; Arginine; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Humans; Peptides, Cyclic; Receptors, Neuropeptide Y; Recombinant Proteins | 1998 |
Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype.
Topics: Animals; Arginine; Blood Glucose; Humans; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1998 |
Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines.
Topics: Animals; Arginine; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Humans; Hydrogen-Ion Concentration; Kinetics; Neuropeptide Y; Radioligand Assay; Receptors, Neuropeptide Y; Tumor Cells, Cultured | 1998 |
Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Topics: Animals; Arginine; Diazepam; Energy Intake; Feeding Behavior; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Starvation | 1998 |
Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors.
Topics: Animals; Anticonvulsants; Arginine; Electroencephalography; Hippocampus; Injections; Limbic System; Male; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Seizures | 1998 |
Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice.
Topics: Aging; Animals; Arginine; Blood Glucose; Body Weight; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Leptin; Mice; Mice, Inbred C57BL; Mice, Obese; Neuropeptide Y; Obesity; Organ Size; Pancreas; Perfusion; Phlorhizin; Proteins; Receptors, Leptin; Receptors, Neuropeptide Y; Regional Blood Flow | 1998 |
NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test.
Topics: Animals; Anxiety; Arginine; Interpersonal Relations; Male; Mesencephalon; Microinjections; Peptides, Cyclic; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Synaptic Transmission | 1998 |
Increased neuropeptide Y pressor activity in Goldblatt hypertensive rats: in vivo studies with BIBP 3226.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Kidney; Male; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Artery | 1998 |
Mechanism of the acute pressor effect and bradycardia elicited by diaspirin crosslinked hemoglobin in anesthetized rats.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Blood Substitutes; Bradycardia; Enzyme Inhibitors; Hemoglobins; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Vagotomy | 1998 |
NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures.
Topics: Arginine; Binding Sites; Calcium; Cell Line; Guanidines; Humans; Imidazoles; Models, Molecular; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1998 |
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor.
Topics: Amino Acid Sequence; Animals; Arginine; Cloning, Molecular; Conserved Sequence; COS Cells; Gene Expression; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Molecular Sequence Data; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Receptors, Neuropeptide Y; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection | 1998 |
Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Cloning, Molecular; DNA Primers; DNA, Complementary; Dogs; Humans; In Situ Hybridization; Kidney; Molecular Sequence Data; Peptide YY; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Species Specificity; Spleen; Swine; Vasoconstriction | 1998 |
Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.
Topics: Animals; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide YY; Prostaglandins; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Thromboxane; Vasoconstriction | 1998 |
Suppression of sensory C fiber-mediated contractions by neuropeptide Y Y1 receptors in the guinea pig bronchi.
Topics: Animals; Arginine; Bronchi; Bronchoconstriction; Guinea Pigs; Humans; In Vitro Techniques; Nerve Fibers; Neuropeptide Y; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y | 1998 |
Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
Topics: Animals; Arginine; Calcium; Calcium-Transporting ATPases; CHO Cells; Cricetinae; Cyclic AMP; Cytosol; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Humans; Inositol Phosphates; Neuropeptide Y; Pertussis Toxin; Receptors, Neuropeptide Y; Recombinant Proteins; Thapsigargin; Type C Phospholipases; Virulence Factors, Bordetella | 1998 |
Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Heart Rate; Lipopolysaccharides; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Shock, Hemorrhagic; Shock, Septic; Vasoconstriction | 1998 |
NPY receptor subtypes involved in the contraction of the proximal colon of the rat.
Topics: Animals; Arginine; Atropine; Colon; Diamines; Gene Expression; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Neuropeptide Y; Peptide Fragments; Peptide YY; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Tetrodotoxin | 1998 |
Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Topics: Animals; Anxiety; Arginine; Brain; Exploratory Behavior; Injections, Intraventricular; Male; Maze Learning; Microinjections; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1998 |
Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?
Topics: Animals; Arginine; Eating; Humans; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swine | 1998 |
The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Eating; Injections; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Stereoisomerism | 1998 |
BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion.
Topics: Animals; Anti-Anxiety Agents; Arginine; Calcium; Cattle; Cells, Cultured; Chromaffin Cells; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Epinephrine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Receptors, Neuropeptide Y; Receptors, Nicotinic | 1998 |
Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Anti-Anxiety Agents; Arginine; Blood Vessels; Humans; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Prazosin; Purinergic Antagonists; Receptors, Neuropeptide Y; Receptors, Purinergic; Saphenous Vein; Suramin; Sympathetic Nervous System; Vasomotor System | 1999 |
Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Topics: Animals; Arginine; Eating; Feeding Behavior; Humans; Injections, Intraventricular; Male; Mice; Neuropeptide Y; Peptides, Cyclic; Psychomotor Performance; Receptors, Neuropeptide; Receptors, Neuropeptide Y | 1999 |
Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Topics: Animals; Arginine; Dinoprost; Drug Synergism; Endothelin-1; Endothelium, Vascular; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Norepinephrine; Peptide Fragments; Potassium Chloride; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Serotonin; Vasoconstriction | 1999 |
Neuropeptide Y and ATP interact to control renovascular resistance in the rat.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Arginine; Culture Techniques; Kidney; Male; Neuropeptide Y; Norepinephrine; Phentolamine; Pressoreceptors; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Sensitivity and Specificity; Vascular Resistance; Vasoconstriction | 1999 |
Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Avoidance Learning; Conditioning, Operant; Grooming; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1999 |
Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
Topics: Animals; Anticonvulsants; Arginine; Cerebral Cortex; Evoked Potentials; Hippocampus; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1999 |
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
Topics: Animals; Arginine; Arginine Vasopressin; Corticotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Male; Neuropeptide Y; Peptides; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Somatostatin | 1999 |
The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Cats; Dose-Response Relationship, Drug; Ligation; Neuropeptide Y; Receptors, Neuropeptide Y | 1999 |
ATP release and degradation in the kidney: modulatory role of neuropeptide Y (NPY).
Topics: Adenosine Triphosphate; Animals; Arginine; Kidney; Neuropeptide Y; Rats | 1999 |
Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Topics: Animals; Arginine; Biotransformation; Cell Membrane; Cerebral Cortex; GABA-B Receptor Agonists; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine Triphosphate; Magnesium Chloride; Male; Neuropeptide Y; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stimulation, Chemical | 1999 |
The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure.
Topics: Animals; Arginine; Blood Pressure; Chronic Disease; Heart Failure; Heart Rate; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke Volume; Ventricular Function, Left | 1999 |
Actions of neuropeptide Y on the rat adrenal cortex.
Topics: Adrenal Cortex; Adrenergic beta-Antagonists; Aldosterone; Animals; Arginine; Atenolol; Catecholamines; Neuropeptide Y; Pancreatic Polypeptide; Rats; Receptors, Neuropeptide Y; RNA, Messenger; Steroids | 2000 |
Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
Topics: Animals; Arginine; Blood Pressure; Cardiovascular System; Decerebrate State; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; In Vitro Techniques; Kidney; Male; Myocardial Ischemia; Neuropeptide Y; Norepinephrine; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Renal Artery; Sodium | 1999 |
Molecular dynamics of NPY Y1 receptor activation.
Topics: Arginine; Binding Sites; Humans; In Vitro Techniques; Ligands; Models, Molecular; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Protein Conformation; Receptors, Neuropeptide Y; Static Electricity; Thermodynamics | 1999 |
Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Arginine; Binding, Competitive; Epilepsy; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Neuropeptide Y; Patch-Clamp Techniques; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses | 2000 |
Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells.
Topics: Animals; Arginine; Cattle; Cells, Cultured; CHO Cells; Chromaffin Cells; Cricetinae; Cyclic AMP; Receptors, Neuropeptide Y | 2000 |
Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Topics: Arginine; Arteries; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vasodilation | 2000 |
Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors.
Topics: Animals; Anticonvulsants; Arginine; Convulsants; Kainic Acid; Male; Neuropeptide Y; Neuropeptides; Octreotide; Pentylenetetrazole; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Neuropeptide Y; Receptors, Somatostatin; Seizures; Somatostatin | 2000 |
Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Topics: Animals; Anxiety; Arginine; Dose-Response Relationship, Drug; Eating; Male; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Corticotropin; Receptors, Neuropeptide Y; Time Factors | 2000 |
Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
Topics: Animals; Arginine; Calcium; Calcium Channels, L-Type; Cell Nucleus; Chick Embryo; Cytosol; Dose-Response Relationship, Drug; Humans; Muscle, Smooth, Vascular; Myocardium; Neuropeptide Y | 2000 |
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Injections, Intraventricular; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes.
Topics: Adipocytes; Adult; Arginine; Binding Sites; Cell Membrane; Cells, Cultured; DNA, Complementary; Dose-Response Relationship, Drug; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Leptin; Ligands; Lipolysis; Middle Aged; Naphthalenes; Peptides; Protein Binding; Pyrrolidines; Receptors, Leptin; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2000 |
Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Topics: Animals; Anti-Anxiety Agents; Arginine; Autoradiography; Down-Regulation; Electric Stimulation Therapy; Epilepsy; Gene Expression; Hippocampus; In Situ Hybridization; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Seizures | 2000 |
Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2000 |
Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.
Topics: Animals; Arginine; Drug Design; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Conformation; Molecular Structure; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship; Swine; Tumor Cells, Cultured | 2000 |
Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
Topics: Arginine; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Chelating Agents; Corticotropin-Releasing Hormone; Egtazic Acid; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuropeptide Y; Pertussis Toxin; Pregnancy; Receptors, Neuropeptide Y; Trophoblasts; Virulence Factors, Bordetella | 2000 |
Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Arginine; Dogs; Drug Interactions; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Tissue; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2000 |
Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
Topics: Adenosine Triphosphate; Animals; Arginine; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Adrenergic; Receptors, Neuropeptide Y; Receptors, Purinergic; Splenic Artery; Synaptic Transmission; Vasoconstriction | 2000 |
Regulation of food intake by neuropeptide Y in goldfish.
Topics: Animals; Anti-Anxiety Agents; Arginine; Body Weight; Brain Chemistry; Diet; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Food Deprivation; Gene Expression; Goldfish; Growth Hormone; Injections, Intraventricular; Male; Neuropeptide Y; Receptors, Neuropeptide Y; RNA, Messenger; Third Ventricle | 2000 |
Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arginine; Arteries; Calcium Channel Blockers; Calcium Channels; Cold Temperature; Ear; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Nitric Oxide Synthase; Norepinephrine; Phentolamine; Purinergic Antagonists; Rabbits; Receptors, Neuropeptide Y; Skin; Sympathetic Nervous System; Vasoconstriction; Verapamil | 2000 |
Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein.
Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Mesenteric Veins; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Reserpine; Sympathetic Nervous System; Vasoconstriction | 2000 |
Identification and characterization of two G protein-coupled receptors for neuropeptide FF.
Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Brain; Calcium; Chromosome Mapping; Cloning, Molecular; COS Cells; Cyclic AMP; DNA, Complementary; Electrophysiology; Gene Library; Humans; Kinetics; Ligands; Molecular Sequence Data; Oligopeptides; Oocytes; Phosphatidylinositols; Protein Binding; Protein Structure, Tertiary; Rats; Receptors, Cell Surface; Receptors, Neuropeptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution; Xenopus | 2000 |
Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors.
Topics: Aging; Animals; Arginine; Body Weight; Female; Hypothalamus; Luteinizing Hormone; Neuropeptide Y; Pituitary Gland; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Sexual Maturation; Vagina; Weight Gain | 2000 |
Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
Topics: Animals; Arginine; In Vitro Techniques; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Neuropeptide Y; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Vasoconstriction; Vasodilation | 2001 |
Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Arginine; Colonic Neoplasms; Humans; Neuropeptide Y; Pancreatic Polypeptide; Peptides, Cyclic; Receptors, Neuropeptide Y; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Somatostatin; Structure-Activity Relationship; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 2001 |
Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons.
Topics: Animals; Arginine; Barium; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Neuronal Plasticity; Neurons; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin; Thalamus | 2001 |
Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa.
Topics: Animals; Arginine; Binding, Competitive; Cloning, Molecular; Colon; Dose-Response Relationship, Drug; Electrophysiology; Female; Ion Transport; Male; Mice; Mucous Membrane; Pancreatic Polypeptide; Receptors, Neuropeptide Y | 2001 |
Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration.
Topics: Alcohol Drinking; Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Ethanol; Hypothalamus; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Long-Evans; Water | 2001 |
Neuropeptide Y functions as a neuroproliferative factor.
Topics: Animals; Arginine; Cell Count; Cell Division; Cells, Cultured; Epithelial Cells; Gene Targeting; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neurons; Neuropeptide Y; Olfactory Mucosa; Olfactory Receptor Neurons; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2001 |
Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226.
Topics: Animals; Anti-Anxiety Agents; Arginine; Binding, Competitive; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Humans; Ligands; Peptides, Cyclic; Rats; Receptors, Neuropeptide; Spinal Cord; Transfection | 2001 |
Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat.
Topics: Acute Disease; Animals; Arginine; Catheterization; Central Nervous System; Electrophysiology; Hyperglycemia; Hypothalamus; Injections, Intraventricular; Male; Muscle Relaxation; Muscle, Smooth; Neuropeptide Y; Pylorus; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reference Values; Stomach | 2001 |
The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Arginine; Arginine Vasopressin; Carrier Proteins; Corticosterone; Corticotropin-Releasing Hormone; Culture Techniques; Hypothalamus; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Kinetics; Male; Neuropeptide Y; Neuropeptides; Norepinephrine; Orexins; Pituitary Gland; Rats; Rats, Wistar | 2001 |
Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish, Carassius auratus.
Topics: Animals; Arginine; Carrier Proteins; Dose-Response Relationship, Drug; Drug Interactions; Eating; Feeding Behavior; Galanin; Goldfish; Humans; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Peptide Fragments; Rats; Receptors, G-Protein-Coupled; Receptors, Galanin; Receptors, Neuropeptide; Receptors, Neuropeptide Y; RNA, Messenger; Signal Transduction; Time Factors | 2001 |
Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
Topics: Animals; Arginine; Calcium; CHO Cells; Cricetinae; Cytosol; Kinetics; Neuropeptide Y; Receptors, Neuropeptide Y; Stereoisomerism; Transfection | 2001 |
Involvement of NPY Y2 receptor subtype in the control of the spontaneous NO/GnRH release at the rat median eminence.
Topics: Animals; Anti-Anxiety Agents; Arginine; Benzazepines; Endothelium, Vascular; Estrous Cycle; Female; Gonadotropin-Releasing Hormone; Median Eminence; Neuropeptide Y; Nitric Oxide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.
Topics: Arginine; Calcium; Cell Line; Concanavalin A; Endosomes; Green Fluorescent Proteins; GTP-Binding Proteins; Humans; Hypertonic Solutions; Kinetics; Luminescent Proteins; Models, Biological; Neuropeptide Y; Phosphorylation; Protein Transport; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Signal Transduction; Spectrometry, Fluorescence; Stress, Mechanical; Sucrose; Transfection | 2002 |
Separate modulation of neuropeptide Y1 receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic artery.
Topics: Animals; Anti-Anxiety Agents; Arginine; Dogs; Electric Stimulation; Female; Male; Neuroeffector Junction; Neuropeptide Y; Receptors, Adrenergic; Receptors, Neuropeptide Y; Receptors, Purinergic; Splenic Artery; Vasoconstriction | 2001 |
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat.
Topics: Animals; Arginine; Brain; Electron Spin Resonance Spectroscopy; Injections, Intra-Arterial; Injections, Intraventricular; Male; Neuropeptide Y; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke | 2002 |
Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
Topics: Animals; Arginine; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart Ventricles; Humans; Male; Myosin Light Chains; Neuropeptide Y; Peptide Fragments; Protein Synthesis Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Time Factors | 2002 |
The direct stimulation of Gi proteins by neuropeptide Y (NPY) in the rat left ventricle.
Topics: Animals; Antibodies; Arginine; Cell Membrane; Colforsin; Cyclic AMP; Drug Interactions; GTP Phosphohydrolases; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine Triphosphate; Heart Ventricles; Hydrolysis; Kinetics; Male; Neuropeptide Y; Rats; Rats, Wistar; Ventricular Function, Left | 2002 |
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.
Topics: Animals; Arginine; CHO Cells; Cricetinae; Humans; Receptors, Neuropeptide; Structure-Activity Relationship; Transfection | 2002 |
Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Topics: 5' Untranslated Regions; Alternative Splicing; Animals; Arginine; Base Sequence; Brain; Cloning, Molecular; Codon, Initiator; COS Cells; Humans; Molecular Sequence Data; Neuropeptide Y; Protein Biosynthesis; Protein Isoforms; Receptors, Neuropeptide Y; RNA, Messenger; Transcription, Genetic; Trinucleotide Repeats | 2003 |
Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade.
Topics: Animals; Anticonvulsants; Arginine; Calcium; Electroshock; Extracellular Space; Hippocampus; Male; Microdialysis; Neuropeptide Y; Potassium Chloride; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Seizures | 2002 |
Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
Topics: Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart; Heart Rate; Male; Mice; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Parasympathetic Nervous System; Receptors, Neuropeptide Y; Vagus Nerve | 2002 |
Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2003 |
Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Topics: Animals; Arginine; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclohexanes; Drug Interactions; Glutamic Acid; Hippocampus; Ionomycin; Ionophores; Neurons; Neuropeptide Y; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptide Fragments; Potassium Chloride; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Neuropeptide Y; Synaptosomes; Xanthenes | 2003 |
Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation.
Topics: Animals; Arginine; Cattle; Cells, Cultured; Chromaffin Cells; Chromatography, High Pressure Liquid; Colforsin; Culture Media, Conditioned; Cyclic AMP; In Vitro Techniques; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pertussis Toxin; Radioimmunoassay; Receptors, Neuropeptide Y | 2000 |
Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists; Animals; Arginine; Cell Membrane; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Female; In Vitro Techniques; Male; Membrane Potentials; Neuropeptide Y; Patch-Clamp Techniques; Peptide YY; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Transmission; Vagus Nerve; Yohimbine | 2003 |
Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arginine; Arteries; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Suramin; Sympathetic Nervous System; Synaptic Transmission; Tail; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Topics: Animals; Arginine; Benzazepines; Colon; Electric Stimulation; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Sex Characteristics; Tetrodotoxin | 2003 |
Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Benzazepines; Corticotropin-Releasing Hormone; Excitatory Amino Acid Agonists; Gastric Acid; Kainic Acid; Male; Microinjections; Neurons; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y | 2003 |
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Topics: Alanine; Aminoisobutyric Acids; Animals; Arginine; Benzazepines; Brain; Carbon Radioisotopes; Cell Line; Iodine Radioisotopes; Male; Naphthalenes; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides, Cyclic; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substrate Specificity; Time Factors; Transformation, Genetic | 2003 |
Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer.
Topics: Animals; Anti-Anxiety Agents; Aorta; Arginine; Bradykinin; Bradykinin B2 Receptor Antagonists; Capillary Permeability; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Indomethacin; Male; Neuropeptide Y; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2004 |
Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
Topics: Alcohol Drinking; Amygdala; Animals; Arginine; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Injections, Intraventricular; Male; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Self Administration | 2003 |
Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin.
Topics: Animals; Arginine; Benzazepines; Bicuculline; Capsaicin; Foot; GABA Antagonists; Inflammation; Injections, Spinal; Laser-Doppler Flowmetry; Male; Pain; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Skin; Spinal Cord; Sympathectomy; Sympathetic Nervous System | 2004 |
Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
Topics: Animals; Apoptosis; Arginine; Bromodeoxyuridine; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred ICR; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neuropeptide Y; Receptors, Neuropeptide Y; Time Factors | 2004 |
Neuropeptide Y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery.
Topics: Animals; Aorta, Thoracic; Arginine; Dose-Response Relationship, Drug; Drug Synergism; Femoral Artery; Gene Expression; Humans; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Serotonin | 2003 |
Y1- and alpha1-receptor control of basal hindlimb vascular tone.
Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Femoral Artery; Heart Rate; Hindlimb; Male; Muscle Tonus; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Regional Blood Flow | 2004 |
Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.
Topics: Analgesics; Animals; Arginine; Calcitonin Gene-Related Peptide; Capsaicin; Exocytosis; Fluorescent Antibody Technique; Ganglia, Spinal; In Vitro Techniques; Male; Neurons, Afferent; Neuropeptide Y; Nociceptors; Peptide Fragments; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Drug; Receptors, Neuropeptide Y | 2004 |
Functional properties of Pfr(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors.
Topics: Animals; Arginine; Binding, Competitive; Cell Membrane; CHO Cells; Cricetinae; Digitonin; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Neuropeptides; Receptors, Neuropeptide; Recombinant Proteins; Sodium; Tetrahydroisoquinolines | 2003 |
Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans.
Topics: Adult; Arginine; Blood Vessels; Cold Temperature; Drug Combinations; Fingers; Humans; Isotonic Solutions; Male; Neuropeptide Y; Norepinephrine; Propranolol; Reflex; Regional Blood Flow; Ringer's Solution; Skin; Skin Physiological Phenomena; Skin Temperature; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System; Yohimbine | 2004 |
Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Blotting, Western; Female; Femoral Artery; Heart Rate; Hindlimb; Immunoassay; Male; Neuropeptide Y; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow; Sex Characteristics | 2005 |
Up-regulation of neuropeptide Y receptors in the hypothalamus of monosodium glutamate-lesioned Sprague-Dawley rats.
Topics: Animals; Arginine; Body Weight; Eating; Hypothalamus; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sodium Glutamate | 2004 |
Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats.
Topics: Animals; Arginine; Brain; Colon; Gastrointestinal Motility; Gastrointestinal Transit; Ghrelin; Injections, Intraperitoneal; Injections, Intraventricular; Male; Peptide Hormones; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Third Ventricle | 2005 |
Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Behavior, Animal; Disease Models, Animal; DNA, Antisense; Gene Expression Regulation; Genetic Vectors; Immunohistochemistry; Male; Maze Learning; Neuropeptide Y; Rats; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon.
Topics: Acetylcholine; Animals; Arginine; Biological Assay; Colon, Sigmoid; Enzyme Inhibitors; In Vitro Techniques; Mice; Muscle Contraction; Neuropeptides; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Receptors, Neuropeptide | 2005 |
Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Aging; Animals; Arginine; Dose-Response Relationship, Drug; Electric Stimulation; Kidney; Male; Neuropeptide Y; Norepinephrine; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Receptors, Purinergic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sympathetic Nervous System | 2005 |
Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
Topics: Animals; Anti-Anxiety Agents; Arginine; Brain; Brain Ischemia; Cerebral Arteries; Immunohistochemistry; Male; Neurons; Neuropeptide Y; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reperfusion Injury; Temperature; Time Factors | 2005 |
Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.
Topics: Arginine; Binding Sites; Cell Line; Conserved Sequence; Humans; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Naphthalenes; Protein Binding; Protein Conformation; Pyrrolidines; Receptors, Neuropeptide Y | 2006 |
Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.
Topics: Animals; Arginine; Blood Flow Velocity; Dogs; Motor Activity; Muscle, Skeletal; Physical Conditioning, Animal; Physical Exertion; Receptors, Neuropeptide Y; Vasoconstriction | 2005 |
Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation.
Topics: Animals; Arginine; Brain; Colon; Corticotropin-Releasing Hormone; Gastrointestinal Motility; Ghrelin; Hypothalamus; Male; Microinjections; Neuropeptide Y; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptide Hormones; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stimulation, Chemical | 2005 |
Antagonism of neuropeptide YY1 receptors does not inhibit ethanol's effects on cortical EEG and ERPs in Wistar rats.
Topics: Animals; Arginine; Behavior, Animal; Cerebral Cortex; Cognition; Electroencephalography; Ethanol; Evoked Potentials; Frontal Lobe; Locomotion; Parietal Lobe; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2005 |
Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.
Topics: Animals; Arginine; Barium; Bee Venoms; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Green Fluorescent Proteins; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Membrane Potentials; Mice; Mice, Transgenic; Neural Inhibition; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Peptide Fragments; Peptide YY; Potassium Channel Blockers; Pro-Opiomelanocortin | 2005 |
In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Arginine; Hypothermia; Male; Mice; Oligopeptides; Rats; Rats, Wistar; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Tachycardia; Time Factors | 2006 |
Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Arginine; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Immune Tolerance; Killer Cells, Natural; Male; Morphine; Morphine Dependence; Narcotics; Neuroimmunomodulation; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Inbred Lew; Receptors, Dopamine D1; Receptors, Neuropeptide Y; Spleen; Sympathetic Nervous System | 2006 |
Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.
Topics: Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Arginine; Drug Administration Schedule; Gene Expression Regulation; Immunohistochemistry; In Vitro Techniques; Midline Thalamic Nuclei; Neuropeptide Y; Phosphopyruvate Hydratase; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Valproic Acid | 2006 |
Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Topics: Animals; Anti-Anxiety Agents; Antibody Specificity; Arginine; Catfishes; Female; Growth Hormone; Immunohistochemistry; Luteinizing Hormone; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Receptors, Neuropeptide Y; Reproduction | 2006 |
Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
Topics: Animals; Arginine; Calcium; Cardiotonic Agents; Cell Differentiation; Cell Separation; Cell Size; Electric Stimulation; Hypertrophy, Left Ventricular; Isoproterenol; Male; Membrane Proteins; Myocardial Contraction; Myocytes, Cardiac; Peptide Fragments; Peptide YY; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Neuropeptide Y mediates ghrelin-induced feeding in the goldfish, Carassius auratus.
Topics: Animals; Arginine; Brain; Feeding Behavior; Female; Ghrelin; Goldfish; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Hormones; Receptors, Neuropeptide Y; RNA, Messenger | 2006 |
Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Topics: Animals; Anti-Anxiety Agents; Arginine; Biomarkers; Corticotropin-Releasing Hormone; CREB-Binding Protein; Immunohistochemistry; Injections, Intraventricular; Male; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Third Ventricle | 2007 |
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
Topics: Animals; Arginine; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Immune System; Killer Cells, Natural; Male; Microinjections; Morphine; Neuroimmunomodulation; Nucleus Accumbens; Rats; Rats, Inbred Lew; Receptors, Neuropeptide Y; Spleen | 2008 |
Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist.
Topics: Arginine; Binding Sites; Cell Line, Tumor; Flow Cytometry; Fluorescence; Fluorescent Dyes; Humans; Ligands; Microscopy, Confocal; Molecular Structure; Pyridinium Compounds; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Time Factors | 2007 |
Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Topics: Adenylyl Cyclases; Animals; Arginine; Cell Line; Cell Membrane; Colforsin; Cricetinae; Cyclic AMP; Dimerization; Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Humans; Luciferases, Renilla; Macaca mulatta; Mesocricetus; Microscopy, Confocal; Neuropeptide Y; Peptide Fragments; Radioligand Assay; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Transfection | 2007 |
Ghrelin inhibits sympathetic nervous activity in sepsis.
Topics: Animals; Arginine; Disease Models, Animal; Ghrelin; Injections, Intravenous; Injections, Intraventricular; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Receptors, Neuropeptide Y; Sepsis; Signal Transduction; Substance P; Sympathetic Nervous System; Tumor Necrosis Factor-alpha | 2007 |
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Chlorisondamine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Hydralazine; Hypertension; Pentanoic Acids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Thiazolidines; Vasodilator Agents | 2008 |
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Topics: Animals; Arginine; Brain; Drug Implants; Electric Stimulation; Electrodes, Implanted; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2008 |
The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans.
Topics: Adrenergic alpha-Antagonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adult; Arginine; Axons; Enzyme Inhibitors; Female; Hot Temperature; Humans; Male; Microdialysis; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Propranolol; Receptors, Neuropeptide Y; Receptors, Presynaptic; Reflex; Regional Blood Flow; Skin; Vasodilation; Yohimbine | 2008 |
Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT).
Topics: Adipocytes; Adult; Arginine; Body Mass Index; Cells, Cultured; Female; Ghrelin; Humans; Leptin; Lipogenesis; Lipolysis; Lipoprotein Lipase; Middle Aged; Receptors, Neuropeptide Y; Subcutaneous Fat | 2009 |
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
Topics: Anti-Anxiety Agents; Arginine; Calcium; Cells, Cultured; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Neuropeptide Y; Receptors, Neuropeptide Y | 2008 |
Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Blood Vessels; Body Weight; Collateral Circulation; Heart Rate; Hindlimb; Ischemia; Male; Muscle, Skeletal; Phentolamine; Phenylephrine; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Regional Blood Flow; Vasoconstriction; Vasodilator Agents | 2008 |
Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
Topics: Age of Onset; Alleles; Animals; Arginine; Atherosclerosis; Female; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Lod Score; Male; Mice; Mice, Transgenic; Middle Aged; Neuropeptide Y; Polymorphism, Genetic; Receptors, Neuropeptide Y | 2009 |
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Arginine; Benzazepines; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Genetic Vectors; Humans; Mice; Mice, Transgenic; Neprilysin; Nerve Degeneration; Nerve Growth Factors; Neurons; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y | 2009 |
Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Imipramine; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neuropeptide Y; Olfactory Bulb; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2009 |
Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Topics: Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Eating; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substance Withdrawal Syndrome; Time Factors | 2009 |
Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Topics: Activating Transcription Factor 1; Animals; Anti-Anxiety Agents; Arginine; Blotting, Western; Cell Line; Culture Media, Conditioned; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Gonadotropin-Releasing Hormone; Neurons; Neuropeptide Y; Phosphorylation; Radioimmunoassay; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2009 |
Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Arginine; Formaldehyde; Hot Temperature; Injections, Intraventricular; Male; Narcotic Antagonists; Neuropeptide Y; Neuropeptides; Oligopeptides; Pain; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, G-Protein-Coupled; Spinal Cord | 2009 |
Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Topics: Analgesics, Opioid; Animals; Arginine; Behavior, Animal; Drug Tolerance; Hyperalgesia; Male; Morphine; Neuropeptide Y; Pain Measurement; Peripheral Nervous System Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sciatic Nerve; Substance Withdrawal Syndrome | 2009 |
Multiple primary cilia modulate the fluid transcytosis in choroid plexus epithelium.
Topics: Animals; Anti-Anxiety Agents; Arginine; Autocrine Communication; Base Sequence; Caco-2 Cells; Cattle; Cell Line, Tumor; Cerebrospinal Fluid; Choroid Plexus; Cilia; Cyclic AMP; Epithelium; Humans; Mice; Models, Biological; Molecular Sequence Data; Oligopeptides; Protein Transport; Rats; Receptors, Neuropeptide; Swine | 2010 |
Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Arcuate Nucleus of Hypothalamus; Arginine; Central Nervous System Agents; Diazepam; Dose-Response Relationship, Drug; Electroshock; Immunohistochemistry; Male; Mice; Neuropeptide Y; Neuropsychological Tests; Nucleus Accumbens; Pregnanolone; Receptors, Neuropeptide Y; Septal Nuclei | 2010 |
NPY mediates ATP-induced neuroproliferation in adult mouse olfactory epithelium.
Topics: Adenosine Triphosphate; Aging; Animals; Arginine; Cell Proliferation; Dose-Response Relationship, Drug; Male; Mice; Models, Neurological; Neurogenesis; Neuropeptide Y; Olfactory Mucosa; Purinergic Antagonists; Pyridoxal Phosphate; Receptors, Neuropeptide Y; Receptors, Purinergic; Sensory Receptor Cells | 2010 |
Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
Topics: Animals; Arginine; Blood Pressure; Estradiol; Female; Heart Rate; Hindlimb; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Neuropeptide Y; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow | 2010 |
Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.
Topics: Adenylyl Cyclases; Animals; Arginine; Calcium; Embryo, Mammalian; Female; Gonadotropin-Releasing Hormone; Immunohistochemistry; In Vitro Techniques; Mice; Neurons; Neuropeptide Y; Polymerase Chain Reaction; Pregnancy; Receptors, Neuropeptide Y; Signal Transduction | 2010 |
Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Body Temperature; Eating; Energy Metabolism; Gastric Emptying; Grooming; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Naloxone; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, Opioid, mu; Receptors, Somatostatin; Somatostatin | 2010 |
N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.
Topics: Acylation; Arginine; Humans; Kinetics; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2010 |
NPY promotes chemokinesis and neurogenesis in the rat subventricular zone.
Topics: Animals; Animals, Newborn; Arginine; Bromodeoxyuridine; Calcium; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebral Ventricles; Enzyme Inhibitors; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Neurons; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger | 2011 |
High expression of NPY receptors in the human testis.
Topics: Adult; Arginine; Benzazepines; Binding, Competitive; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Leydig Cells; Male; Middle Aged; Receptors, Neuropeptide Y; Seminoma; Teratoma; Testicular Neoplasms; Testis; Young Adult | 2011 |
Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Agmatine; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Clonidine; Drug Synergism; Eating; Feeding Behavior; Hyperphagia; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Yohimbine | 2011 |
Refeeding after a 24-hour fasting deepens NREM sleep in a time-dependent manner.
Topics: Analysis of Variance; Angiotensin II; Animals; Anti-Anxiety Agents; Arginine; Blood Glucose; Body Temperature; Circadian Rhythm; Delta Rhythm; Drinking; Electroencephalography; Fasting; Fatty Acids; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Neuropeptide Y; Nitric Oxide Synthase Type I; RNA, Messenger; Sleep Stages; Triglycerides; Wakefulness | 2011 |
Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Arginine; Biogenic Monoamines; Biosensing Techniques; Brain Chemistry; Catecholamines; Depression; Electrochemistry; Fluoxetine; Imipramine; Indoles; Male; Neuropeptide Y; Neuropeptides; Oxidation-Reduction; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Selective Serotonin Reuptake Inhibitors | 2011 |
Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Arginine; Cell Membrane; Glucose; Glucose Transporter Type 4; Insulin; Mice; Neuropeptide Y; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Neuropeptide Y; Up-Regulation | 2012 |
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Newborn; Arginine; Autoradiography; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Female; Functional Laterality; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neurodegenerative Diseases; Neuropeptide Y; Neuroprotective Agents; Nortropanes; Oligopeptides; Oxidopamine; Parkinson Disease; Protein Binding; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim.
Topics: Animals; Antidepressive Agents; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Fluoxetine; Folic Acid; Injections, Intraventricular; Locomotion; Neuropeptide Y; Ovariectomy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Septal Nuclei; Swimming | 2011 |
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
Topics: Alcohol Drinking; Amygdala; Analysis of Variance; Animals; Arginine; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Neurons; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y | 2012 |
Neuropeptide Y stimulates food intake in the Zebrafish, Danio rerio.
Topics: Animals; Arginine; Behavior, Animal; Brain; Eating; Feeding Behavior; Female; Hormone Antagonists; Hypothalamus; Infusions, Intraventricular; Male; Neuropeptide Y; Nutritional Status; Receptors, Neuropeptide Y; Zebrafish | 2012 |
Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amygdala; Analysis of Variance; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Colchicine; Dentate Gyrus; Disease Models, Animal; Escape Reaction; Learning; Male; Maze Learning; Memory; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2012 |
Selective mode of action of guanidine-containing non-peptides at human NPFF receptors.
Topics: Adamantane; Amino Acid Substitution; Animals; Arginine; Binding Sites; Biological Assay; Chlorocebus aethiops; COS Cells; Dipeptides; Drug Design; Guanidine; HEK293 Cells; Humans; Ligands; Microscopy, Fluorescence; Molecular Conformation; Peptidomimetics; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Structure-Activity Relationship | 2012 |
Y1R control of sciatic nerve blood flow in the Wistar Kyoto rat.
Topics: Animals; Arginine; Arteries; Ganglionic Blockers; Hexamethonium; Neuropeptide Y; Rats; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Regional Blood Flow; Sciatic Nerve; Signal Transduction; Ultrasonography, Doppler, Pulsed; Vasodilation | 2012 |
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Topics: Animals; Arginine; Cell Proliferation; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucagon-Like Peptide 1; Male; Models, Animal; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Proline; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sitagliptin Phosphate; Thymidine; Triazoles | 2012 |
Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide.
Topics: Analgesia; Analgesics, Opioid; Animals; Arginine; Dose-Response Relationship, Drug; Endorphins; Guinea Pigs; Male; Mice; Morphinans; Naloxone; Naltrexone; Neuropeptides; Opioid Peptides; Proline; Receptors, Neuropeptide; Tetrahydroisoquinolines; Time Factors | 2012 |
Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.
Topics: Analysis of Variance; Animals; Arginine; Caspase 3; Corpus Striatum; Cyclic GMP; Drug Interactions; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Neuropeptide Y; Nitric Oxide Synthase Type II; Peptides; Protein Precursors; Receptors, Neuropeptide Y; RNA, Messenger; Tyrosine | 2012 |
Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
Topics: Animals; Appetite Depressants; Appetite Regulation; Arginine; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Down-Regulation; Eating; Gene Knockdown Techniques; Glutathione Peroxidase; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligonucleotides, Antisense; Phenylpropanolamine; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Signal Transduction; Time Factors | 2013 |
Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
Topics: Acetylcholine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Arginine; Blood Pressure; Drug Synergism; Heart Rate; Hindlimb; Male; Muscle, Skeletal; Neuropeptide Y; Nitric Oxide Donors; Nitroprusside; Prazosin; Prediabetic State; Rats; Receptors, Adrenergic, alpha-1; Receptors, Neuropeptide Y; Regional Blood Flow; Vasoconstriction | 2012 |
Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
Topics: Adipokines; Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Cholesterol; Diet, High-Fat; Immunohistochemistry; Interleukin-12; Lipids; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Plaque, Atherosclerotic; Real-Time Polymerase Chain Reaction; Receptors, Neuropeptide Y; Vascular Cell Adhesion Molecule-1 | 2013 |
Blockage of peripheral NPY Y1 and Y2 receptors modulates barorefex sensitivity of diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Experimental; Heart Rate; Hyperlipidemias; Male; Neuropeptide Y; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Triglycerides | 2013 |
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes | 2013 |
Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway.
Topics: Animals; Arginine; Butadienes; Cells, Cultured; Enzyme Inhibitors; HMGB1 Protein; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuroimmunomodulation; Neuropeptide Y; Nitriles; Protein Kinase C; Receptors, Neuropeptide Y; Staurosporine | 2013 |
Effect of neuropeptide Y on food intake in bullfrog larvae.
Topics: Animals; Anti-Anxiety Agents; Appetite Regulation; Arginine; Eating; Fasting; Feeding Behavior; Hypothalamus; Larva; Neuropeptide Y; Rana catesbeiana; Receptors, Neuropeptide Y; RNA, Messenger | 2013 |
High vascular tone of mouse femoral arteries in vivo is determined by sympathetic nerve activity via α1A- and α1D-adrenoceptor subtypes.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Fibers; Animals; Arginine; Calcium; Femoral Artery; Isoquinolines; Mice; Microscopy, Fluorescence; Muscle Tonus; Muscle, Smooth, Vascular; Myography; Myosin-Light-Chain Kinase; Naphthyridines; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; Suramin; Thymine | 2013 |
Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Topics: Agmatine; Animals; Antidepressive Agents; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Injections, Intraventricular; Male; Motor Activity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming | 2013 |
Inhibition of peripheral NPY Y1 and Y2 receptors ameliorates the aberrant baroreceptor reflex sensitivity in streptozotocin induced diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Bradycardia; Diabetes Mellitus, Experimental; Heart Rate; Myocardial Contraction; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Streptozocin | 2013 |
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
Topics: Arginine; Dimerization; Fura-2; Guanidine; Humans; Models, Molecular; Protein Binding; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Urea | 2013 |
Noradrenaline and neuropeptide Y contribute to initial, but not sustained, vasodilatation in response to local skin warming in humans.
Topics: Adult; Arginine; Clonidine; Humans; Male; Neuropeptide Y; Nitric Oxide Synthase Type III; Nitroprusside; Norepinephrine; Propranolol; Skin; Skin Temperature; Vasodilation; Yohimbine | 2014 |
The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Appetite; Arginine; Chromatin Immunoprecipitation; Feeding Behavior; Gene Knockdown Techniques; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Transcription Factor AP-1 | 2013 |
Neuropeptide Y regulates the leptin receptors in rat hypothalamic and pituitary explant cultures.
Topics: Animals; Arginine; Female; Gene Expression; Gonadotropin-Releasing Hormone; Hypothalamus; Luteinizing Hormone; Neuropeptide Y; Ovulation; Pituitary Gland; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Receptors, Neuropeptide Y; Tissue Culture Techniques | 2014 |
Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.
Topics: Animals; Arginine; Body Weight; Brain; Corticotropin-Releasing Hormone; Eating; Ghrelin; Male; Neurons; Neuropeptide Y; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Somatostatin | 2014 |
Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Topics: Agmatine; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Cell Count; Central Amygdaloid Nucleus; Immunohistochemistry; Male; Motor Activity; Neuropeptide Y; Neuropsychological Tests; Nucleus Accumbens; Photomicrography; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2014 |
Involvement of amygdaloid neuropeptide Y in the anxiolytic effects of acupuncture during ethanol withdrawal in rats.
Topics: Acupuncture Therapy; Amygdala; Animals; Anxiety; Arginine; Benzazepines; Cyclic AMP Response Element-Binding Protein; Ethanol; Male; Maze Learning; Neuropeptide Y; Phosphorylation; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2014 |
Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arginine; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Mice; Motor Activity; Neuropeptide Y; Neuropsychological Tests; Psychotropic Drugs; Receptors, Neuropeptide Y; Social Behavior; Swimming; Tetragastrin | 2014 |
Neuropeptide Y is crucial for nutritional state-dependent regulation of maternal behavior.
Topics: Animals; Arginine; Dorsal Raphe Nucleus; Energy Intake; Fasting; Female; GABAergic Neurons; Maternal Behavior; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Serotonergic Neurons | 2015 |
Kisspeptin regulation of arcuate neuron excitability in kisspeptin receptor knockout mice.
Topics: Adamantane; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Dipeptides; Kisspeptins; Mice; Mice, Knockout; Neuroendocrine Cells; Neuropeptides; Patch-Clamp Techniques; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, Neuropeptide | 2015 |
Neuropeptide FF receptors as novel targets for limbic seizure attenuation.
Topics: Adamantane; Animals; Anticonvulsants; Arginine; CHO Cells; Cricetulus; Dipeptides; Disease Models, Animal; HEK293 Cells; Humans; Limbic System; Male; Pilocarpine; Rats, Wistar; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Seizures | 2015 |
Effects of direct QRFP-26 administration into the medial hypothalamic area on food intake in rats.
Topics: Animals; Arginine; Behavior, Animal; Eating; Hypothalamus, Middle; Male; Microinjections; Motor Activity; Peptides; Rats; Rats, Wistar | 2015 |
Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
Topics: Animals; Antidepressive Agents, Tricyclic; Arginine; Blood Glucose; Central Amygdaloid Nucleus; Depression; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Imipramine; Male; Mice; Motor Activity; Neuropeptide Y; Nucleus Accumbens; Receptors, Neuropeptide Y; Septal Nuclei; Streptozocin | 2016 |
Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.
Topics: Animals; Arginine; Cell Differentiation; Cell Line; Glucocorticoids; MAP Kinase Signaling System; Mice; Osteoblasts; Receptors, Neuropeptide Y | 2016 |
NPY
Topics: Animals; Animals, Outbred Strains; Arginine; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Isometric Contraction; Myocardial Contraction; Myocardium; Neuropeptide Y; Rats; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Tissue Culture Techniques | 2017 |
Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.
Topics: Administration, Cutaneous; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Arginine; Blood Vessels; Cryotherapy; Female; Humans; Ischemia; Leg; Male; Microdialysis; Propranolol; Receptors, Adrenergic, alpha; Receptors, Neuropeptide Y; Skin; Time Factors; Vasoconstriction; Yohimbine | 2018 |
Gas-phase structural characterization of neuropeptides Y Y1 receptor antagonists using mass spectrometry: Orbitrap vs triple quadrupole.
Topics: Arginine; Limit of Detection; Receptors, Neuropeptide Y; Tandem Mass Spectrometry | 2018 |
Central Neuropeptide Y Plays an Important Role in Mediating the Adaptation Mechanism Against Chronic Stress in Male Rats.
Topics: Adaptation, Physiological; Animals; Arginine; Corticosterone; Corticotropin-Releasing Hormone; Gastrointestinal Motility; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stress, Physiological | 2018 |
Melatonin Induces Osteoblastic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing in a Rat Model of Femoral Fracture via Neuropeptide Y/Neuropeptide Y Receptor Y1 Signaling.
Topics: Alkaline Phosphatase; Animals; Arginine; Cell Differentiation; Collagen Type I; Collagen Type I, alpha 1 Chain; Core Binding Factor Alpha 1 Subunit; Femoral Fractures; Fracture Healing; Male; Melatonin; Mesenchymal Stem Cells; Neuropeptide Y; Osteoblasts; Osteocalcin; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Signal Transduction | 2018 |
Neuropeptide Y impairs the acquisition of conditioned defeat in Syrian hamsters.
Topics: Animals; Arginine; Behavior, Animal; Conditioning, Psychological; Cricetinae; Dominance-Subordination; Infusions, Intraventricular; Male; Neuropeptide Y | 2019 |
Expression of neuropeptide Y is increased in an activated human HSC cell line.
Topics: Adaptor Proteins, Signal Transducing; Arginine; Cell Cycle Proteins; Cell Line, Transformed; Fibrosis; Hepatic Stellate Cells; Humans; Neuropeptide Y; Phosphorylation; Receptors, Neuropeptide Y; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2019 |
Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.
Topics: Animals; Arginine; Benzazepines; Body Weight; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Receptors, Neuropeptide Y | 2019 |
QresFEP: An Automated Protocol for Free Energy Calculations of Protein Mutations in Q.
Topics: Arginine; Automation; Ligands; Molecular Dynamics Simulation; Mutant Proteins; Protein Stability; Receptors, Neuropeptide Y; Software; Thermodynamics | 2019 |
Neuropeptide Y increases differentiation of human olfactory receptor neurons through the Y1 receptor.
Topics: Arginine; Cell Differentiation; Cells, Cultured; Humans; Neuropeptide Y; Olfactory Mucosa; Olfactory Receptor Neurons; Receptors, Neuropeptide Y; Signal Transduction | 2019 |
Determination of neuropeptide Y Y1 receptor antagonist BIBP 3226 and evaluation of receptor expression based on liquid chromatography coupled with tandem mass spectrometry.
Topics: Animals; Arginine; Chromatography, Liquid; Humans; Limit of Detection; Male; MCF-7 Cells; Mice, Inbred C57BL; Receptors, Neuropeptide Y; Tandem Mass Spectrometry | 2020 |
NPY-Y
Topics: Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Ethanol; Male; Maze Learning; Microinjections; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Recurrence | 2020 |